Hongbing Zhang
- Molecular Biology top 1%
- Cancer Research top 1%
- Oncology top 2%
- Physiology top 1%
- Immunology top 2%
- Co-authors
- Allan BradleyDavid J. KwiatkowskiYing WangHiroaki OndaChristoph ReinhardThomas P. NeufeldGregor CicchettiHenry Koon
- Topics
- PI3K/AKT/mTOR signaling in cancer (29 papers)Tuberous Sclerosis Complex Research (27 papers)Cancer, Hypoxia, and Metabolism (12 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Hongbing Zhang
186 papers receiving 9.0k citations
Hit Papers
Peers
Comparison fields: 5 of 146
- Molecular Biology 5.6k
- Cancer Research 1.6k
- Oncology 1.5k
- Physiology 1.4k
- Immunology 1.1k
Countries citing papers authored by Hongbing Zhang
This map shows the geographic impact of Hongbing Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongbing Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongbing Zhang more than expected).
Fields of papers citing papers by Hongbing Zhang
This network shows the impact of papers produced by Hongbing Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongbing Zhang. The network helps show where Hongbing Zhang may publish in the future.
Co-authorship network of co-authors of Hongbing Zhang
This figure shows the co-authorship network connecting the top 25 collaborators of Hongbing Zhang. A scholar is included among the top collaborators of Hongbing Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongbing Zhang. Hongbing Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 1 | |
| 7 | 0 | |
| 8 | 0 | |
| 9 | 5 | |
| 10 | 16 | |
| 11 | 16 | |
| 12 | 58 | |
| 13 | 5 | |
| 14 | 1 | |
| 15 | 64 | |
| 16 | 131 | |
| 17 | Clinical efficacy of the Qubai Babuqi Tablets in the treatment of vitiligo | 2 |
| 18 | Senescence is a defensive mechasim against oncogene-induced tumorigenesis | 1 |
| 19 | 48 | |
| 20 | 3 |
About Hongbing Zhang
Hongbing Zhang is a scholar working on Horticulture, Cancer Research and Molecular Biology, having authored 197 papers that have together received 9.2k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (29 papers), Tuberous Sclerosis Complex Research (27 papers) and Cancer, Hypoxia, and Metabolism (12 papers). The work is most often cited by research in Cancer Research (1.6k citations), Aging (145 citations) and Molecular Biology (5.6k citations). Hongbing Zhang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Allan Bradley, David J. Kwiatkowski, Ying Wang, Hiroaki Onda, Christoph Reinhard, Thomas P. Neufeld, Gregor Cicchetti, Henry Koon, Christopher L. Carpenter and Francisca Vázquez. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.